The Macau Institute for Translational Medicine and Innovation at the University of Macau (UM) held a closed-door seminar on innovation, commercialisation, and high-quality development of Chinese medicine in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), as well as a signing ceremony for the strategic cooperation between the Guangdong Respiratory and Health Association and Fogang County of Qingyuan City. The event aimed to promote the modernisation of the drug regulatory system and regulatory capacity, and to facilitate the development of the Chinese medicine industry in Guangdong, Hong Kong, and Macao. Officials from the drug regulatory authorities of the three places, as well as scholars, professors, and company representatives from all over the country attended the event.
Zhong Nanshan, chair of the seminar, member of the Chinese Academy of Engineering, and president of the Steering Committee of the Macau Institute for Translational Medicine and Innovation; Xu Qingfeng, director of the Traditional Chinese Medicine Bureau of Guangdong Province; Wang Ling, deputy director of the Drug Administration of Guangdong Province, delivered a speech at the seminar respectively. In addition, Zhao Yonghua, interim associate head of the Macau Institute for Translational Medicine and Innovation, announced the publication of the Blue Book of Research Projects on the Regulatory Science of Traditional Chinese Medicine in the Macao SAR. The symposium also included an academic discussion session, a sharing session, and a panel discussion, where participants delivered academic presentations, shared their experiences, and exchanged views.
